Trident Lifeline Ltd

Trident Lifeline Business Update

Trident Lifeline Limited has been selected for the 'Fastest Growing SMEs' award by India SME Forum and Axis Bank in the Top 50 SME Awards - Gujarat.

Trident Lifeline Investor Presentation: Key Takeaways

Trident Lifeline (TLL) achieved ₹129 Cr consolidated revenue in FY26, a 48% increase. Strategy centers on a demand-led manufacturing model and aggressive global registration expansion.

Call

Guides 200% growth

Trident Lifeline Q1 FY27 Results: Net Profit ₹5 Cr, Up 61.3% YoY

Trident Lifeline Ltd reported revenue from operations of ₹33.7 Cr (+42.8% YoY) and net profit of ₹5 Cr (+61.3% YoY) for Q1 FY27.

Key figure

Net profit ₹5 Cr · +61.3% YoY

Trident Lifeline Board Meeting Date

Trident Lifeline Ltd scheduled a Board Meeting for July 29, 2026. The meeting will consider the unaudited financial results for the June 30, 2026 quarter.

Trident Lifeline Annual General Meeting

Trident Lifeline shareholders approved migrating from BSE SME to the Main Board of BSE and NSE. They also confirmed appointing two Independent Directors via postal ballot.

Trident Lifeline SME to Main Board Migration

Trident Lifeline shareholders approved the migration from BSE SME platform to the Main Boards of BSE and NSE. The resolution was passed via postal ballot with majority support.

Trident Lifeline Promoter Buying

Hardik Desai Family Trust, a promoter group entity, acquired 1,200 shares of Trident Lifeline Ltd via open market. This increases promoter holding marginally to 7.78%.

Trident Lifeline Annual General Meeting

Trident Lifeline Ltd seeks shareholder approval via postal ballot for appointing two independent directors and migrating from BSE SME to main board. The e-voting period runs from June 16 to July 15, 2026.

Trident Lifeline Board Meeting Outcome

Trident Lifeline's board approved two independent director appointments and a migration from SME to main board. The moves strengthen governance and signal a growth phase.

Trident Lifeline Merger & Restructuring

Trident Lifeline Limited's stake in subsidiary Trident Mediquip Limited diluted from 59.17% to 58.84%. The change follows the subsidiary's private placement of shares to other investors.

Trident Lifeline Acquisition

Shikha Ashish Bafna acquired 3,000 shares of Trident Lifeline Limited via the open market. The non-promoter acquisition increases the holder's total stake to 0.23%.

Trident Lifeline Promoter Buying

Hardik Desai Family Trust, a promoter group entity, acquired 9,000 shares of Trident Lifeline Limited via the open market. This increases their stake to 7.15%.

Trident Lifeline Earnings Call: Key Takeaways

Trident Lifeline achieved record FY26 revenue exceeding ₹100 crore with a 49% standalone revenue growth. The company maintains a hybrid manufacturing model focused on pharmaceutical formulation exports to emerging markets.

Trident Lifeline H2 FY26 Results: Net Profit ₹11.4 Cr, Up 81.0% YoY

Trident Lifeline Ltd reported revenue from operations of ₹75.7 Cr (+52.6% YoY) and net profit of ₹11.4 Cr (+81.0% YoY) for H2 FY26.

Key figure

Net profit ₹11.4 Cr · +81.0% YoY

Trident Lifeline Financial Results

Trident Lifeline reported standalone annual total income of ₹106.07 Crore for FY26. The board also appointed DAC & Co. as internal auditors for FY27.

Value

₹106.1 Cr

Trident Lifeline Board Meeting Date

Trident Lifeline Ltd has rescheduled its Board Meeting to Thursday, May 07, 2026. The board will consider and approve the Audited Financial Results for the half-year and year ended March 31, 2026. The trading window for designated persons remains closed until 48 hours after the results are public.

Trident Lifeline Debt & Borrowing: ₹16.22 Cr

Trident Lifeline Ltd (TLL) confirmed it is not identified as a 'Large Corporate' as of March 31, 2026, under SEBI's debt fund-raising framework. The company's outstanding borrowings stood at ₹16.22 Crore.

Value

₹16.22 Cr

Trident Lifeline Board Meeting Date

Trident Lifeline Ltd has scheduled a Board Meeting on May 5, 2026, to consider and approve audited financial results for the year ended March 31, 2026. The trading window for company shares remains closed until 48 hours after the results are made public.

Trident Lifeline Other Announcement

Trident Lifeline Limited announced that its subsidiary, Trident Mediquip Limited, allotted equity shares to other shareholders via private placement. Consequently, the company's stake in the subsidiary decreased from 59.47% to 59.17%. The transaction was conducted at arm's length to facilitate further allotment of shares to other investors.

Trident Lifeline Other Announcement

Trident Lifeline Limited's stake in its subsidiary, Trident Mediquip Limited, decreased from 59.77% to 59.47% following a private placement of equity shares by the subsidiary to other shareholders. Trident Mediquip Limited reported a turnover of ₹21.29 Crore for FY 2024-25.